サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1715173

欧州の医療用外骨格市場の予測 (2031年まで) - 地域別分析 (コンポーネント別、種類別、四肢別、用途別、モビリティ別、エンドユーザー別)

Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users

出版日
ページ情報
英文 117 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
欧州の医療用外骨格市場の予測 (2031年まで) - 地域別分析 (コンポーネント別、種類別、四肢別、用途別、モビリティ別、エンドユーザー別)
出版日: 2025年02月11日
発行: The Insight Partners
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の医療用外骨格市場は、2023年に1億748万米ドルと評価され、2031年には8億5,396万米ドルに達すると予測され、2023年から2031年までのCAGRは29.6%と推定されます。

脳卒中と筋骨格系の増加が欧州の医療用外骨格市場を牽引

医療業界の進歩にもかかわらず、脳卒中は公衆衛生上の大きな問題であり続けています。脳卒中は死亡原因において世界第2位であり、身体障害の主な原因でもあります。Global Stroke Factsheet 2022によると、脳卒中を発症する生涯リスクは過去17年間で50%上昇し、推定4人に1人が生涯のどこかで脳卒中を経験すると予想されています。1990年から2019年の間に、脳卒中の発症率は70％、脳卒中に関連する死亡者数は43％、脳卒中の頻度は102％、障害調整生存年（DALY）は143％増加しています。最も注目すべき点は、低・中所得国が世界の脳卒中負担の大部分（脳卒中関連死亡者の86％、DALYの89％）を占めていることです。欧州連合（EU）では、2017年に112万件の脳卒中発症、953万人の脳卒中生存者、46万人の脳卒中関連死亡、706万年の脳卒中による障害による生命喪失がありました。さらに、主に高齢化と生存率の上昇により、2017年から2047年の間に脳卒中患者数は27％増加すると予測されています。国による差は今後も存在すると予想され、特に東欧では症例管理と予防の進歩の可能性を示しています。そのため、脳卒中の発生件数の増加により、生活の質の向上に役立つ脳卒中患者のリハビリテーション用外骨格システムの需要が高まっています。

さらに、筋骨格系の障害は個人の運動能力に影響を与えます。腱炎、骨減少症、サルコペニア、腰痛などの筋骨格系障害の有病率の増加により、外骨格ロボットシステムのニーズが高まっています。世界保健機関（WHO）によると、世界で17億1,000万人が筋骨格系疾患に罹患しており、腰痛は160カ国で障害の主な原因となっています。これらの外骨格は、患者の疼痛管理を支援するだけでなく、運動能力の回復を助け、それによって全体的な生活の質を向上させる。このように、脳卒中や筋骨格系障害の有病率の増加は、リハビリテーションのための外骨格ロボットシステムの使用につながっています。

欧州の医療用外骨格市場の概要

欧州の医療用外骨格市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域は世界の医療用外骨格市場で大きなシェアを占めており、注目すべきCAGRを記録することが期待されています。同国の市場プレーヤーは、市場拡大と成長のためにパートナーシップやコラボレーションなどの無機的成長戦略を採用しています。2022年8月、German Bionic社（スマートパワースーツ開発の世界的技術リーダー）とMubea社（ドイツのトップ自動車サプライヤー）が協力協定を締結しました。世界トップのロボット外骨格開発企業の生産を支援することで、ムベアは将来的に極めて有望な新分野を開拓しました。同様に、2020年4月、ReWalk Robotics Ltd.は、ドイツのトップ法定保険会社（「SHI」）、Deutsche Angestellten-Krankenkasse-Gesundheit（「DAK-Gesundheit」）、Techniker Krankenkasse（「TK」）との国内協定を発表しました。この合意により、脊髄損傷者であれば誰でもReWalk 6.0外骨格システムを手に入れることができます。TKとDAKは、それぞれドイツで1,060万人と560万人の受益者を代表し、ドイツで最大のSHIの2つです。これらの合意は、ドイツにおける外骨格調達の標準を設定するのに役立つと期待されています。

欧州の医療用外骨格市場の収益と2031年までの予測（金額ベース）

欧州の医療用外骨格市場のセグメンテーション

欧州の医療用外骨格市場は、コンポーネント、種類、四肢、用途、モビリティ、エンドユーザー、国に分類されます。

コンポーネント別では、欧州の医療用外骨格市場はハードウェアとソフトウェアに二分されます。2023年の欧州の医療用外骨格市場では、ハードウェアセグメントが大きなシェアを占めています。

種類別では、欧州の医療用外骨格市場は動力式外骨格と受動式外骨格に二分されます。2023年の欧州の医療用外骨格市場では、動力式外骨格セグメントが大きなシェアを占めています。

四肢別では、欧州の医療用外骨格市場は下半身用外骨格、上半身用外骨格、全身用外骨格に区分されます。2023年の欧州の医療用外骨格市場では、下半身用外骨格セグメントが最大シェアを占めています。

用途別では、欧州の医療用外骨格市場は脊髄損傷、多発性硬化症、脳卒中、脳性麻痺、パーキンソン病、その他に区分されます。2023年の欧州の医療用外骨格市場では、脊髄損傷分野が最大シェアを占めています。

モビリティ別では、欧州の医療用外骨格市場は移動式外骨格と据置型外骨格に二分されます。2023年の欧州の医療用外骨格市場では、動力式外骨格セグメントが大きなシェアを占めています。

エンドユーザー別では、欧州の医療用外骨格市場はリハビリセンター、理学療法センター、長期介護センター、在宅介護、その他に区分されます。2023年の欧州の医療用外骨格市場では、リハビリセンター分野が最大シェアを占めています。

国別では、欧州の医療用外骨格市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。ドイツセグメントが2023年の欧州の医療用外骨格市場で最大のシェアを占めています。

BIONIK、B-Temia Inc、Cyberdyne Inc、Ekso Bionics Holdings Inc、ExoAtlet、Hocoma AG、Lifeward, Inc、Myomo Inc、Rex Bionics Ltd.、Wearable Robotics SRは、欧州の医療用外骨格市場で事業展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 市場の魅力

第3章 分析手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 欧州の医療用外骨格市場：主な市場力学

  • 医療用外骨格市場：主な市場力学
  • 市場促進要因
    • 戦略的イニシアチブの増加
    • 脳卒中および筋骨格系の罹患率の増加
    • 高齢者の長寿化
  • 市場抑制要因
    • 製品コストの高騰と規制上の懸念
  • 市場機会
    • SCIの有病率の増加
  • 今後の動向
    • 技術進歩と投資増加
  • 促進要因と抑制要因の影響

第5章 医療用外骨格市場：欧州の分析

  • 欧州の医療用外骨格市場の収益（2021～2031年）
  • 欧州の医療用外骨格市場の予測分析

第6章 欧州の医療用外骨格市場分析：コンポーネント別

  • ハードウェア
  • ソフトウェア

第7章 欧州の医療用外骨格市場の分析：種類別

  • 動力式外骨格
  • 受動式外骨格

第8章 欧州の医療用外骨格市場の分析：四肢別

  • 下半身用外骨格
  • 上半身用外骨格
  • 全身用外骨格

第9章 欧州の医療用外骨格市場の分析：用途別

  • 脊髄損傷
  • 多発性硬化症
  • 脳卒中
  • 脳性麻痺
  • パーキンソン病
  • その他

第10章 欧州の医療用外骨格市場の分析：モビリティ別

  • 移動式外骨格
  • 据置型外骨格

第11章 欧州の医療用外骨格市場の分析：エンドユーザー別

  • リハビリセンター
  • 理学療法センター
  • 長期介護センター
  • 在宅介護
  • その他

第12章 欧州の医療用外骨格市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第13章 医療用外骨格市場：業界情勢

  • 概要
  • 医療用外骨格市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第14章 企業プロファイル

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Wearable Robotics SRL
  • Myomo Inc
  • Rex Bionics Ltd.

第15章 付録

図表

List Of Tables

  • Table 1. Europe Medical Exoskeleton Market Segmentation
  • Table 2. Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Medical Exoskeleton Market, by Hardware - Revenue and Forecast to 2031 (USD Million)
  • Table 4. Europe Medical Exoskeleton Market, by Actuators - Revenue and Forecast to 2031 (USD Million)
  • Table 5. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 6. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 7. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 8. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 9. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 10. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 11. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 12. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 13. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 14. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 15. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 16. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 18. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 19. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 20. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 21. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 22. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 23. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 24. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 26. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 28. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 29. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 30. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 31. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 32. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 34. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 36. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 37. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 38. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 39. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 40. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 41. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 42. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 43. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 44. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 45. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 46. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 47. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 48. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 49. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 50. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 51. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 52. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 53. Recent Organic Growth Strategies in Medical Exoskeleton Market
  • Table 54. Recent Inorganic Growth Strategies in the Medical Exoskeleton Market
  • Table 55. Glossary of Terms, Medical Exoskeleton Market

List Of Figures

  • Figure 1. Europe Medical Exoskeleton Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • Figure 4. Europe Medical Exoskeleton Market Share (%) - by Component (2023 and 2031)
  • Figure 5. Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Europe Medical Exoskeleton Market Share (%) - by Type (2023 and 2031)
  • Figure 8. Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Europe Medical Exoskeleton Market Share (%) - by Extremity (2023 and 2031)
  • Figure 11. Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Europe Medical Exoskeleton Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Europe Medical Exoskeleton Market Share (%) - by Mobility (2023 and 2031)
  • Figure 22. Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Europe Medical Exoskeleton Market Share (%) - by End Users (2023 and 2031)
  • Figure 25. Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Europe Medical Exoskeleton Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 31. Europe Medical Exoskeleton Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 32. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Growth Strategies in Medical Exoskeleton Market
目次
Product Code: BMIRE00031138

The Europe medical exoskeleton market was valued at US$ 107.48 million in 2023 and is expected to reach US$ 853.96 million by 2031; it is estimated to register a CAGR of 29.6% from 2023 to 2031.

Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market

Despite the advancements in the medical industry, stroke continues to be a major public health issue. Stroke ranks second in the world in terms of causes of mortality and is the main cause of disability. According to the Global Stroke Factsheet 2022, the lifetime risk of having a stroke has risen by 50% in the past 17 years, with an estimated 1 in 4 people expected to experience one at some point in their lives. Between 1990 and 2019, there was a rise of 70% in the incidence of stroke, 43% in the number of stroke-related deaths, 102% in the frequency of stroke, and 143% in Disability Adjusted Life Years (DALY). The most notable aspect is that lower- and lower-middle-income countries account for the majority of the world's stroke burden (86% of stroke-related fatalities and 89% of DALYs). In the European Union, there were 1.12 million stroke incidents, 9.53 million stroke survivors, 0.46 million stroke-related deaths, and 7.06 million years of life lost due to disability from stroke in 2017. Further, the number of people living with stroke is predicted to rise by 27% between 2017 and 2047, primarily as a result of aging populations and higher survival rates. It is anticipated that differences will continue to exist between nations, indicating potential for advancements in case management and prevention, especially in Eastern Europe. Therefore, the increasing incidences of stroke have boosted the demand for exoskeleton systems for rehabilitation of stroke patients to help improve the quality of life.

In addition, musculoskeletal disorders impact the mobility of an individual. The increasing prevalence of musculoskeletal disorders, such as tendinitis, osteopenia, sarcopenia, and low back injuries, result in a growing need for exoskeletan robotic systems. According to the World Health Organization (WHO), ~1.71 billion people globally are affected by musculoskeletal diseases, and lower back pain is a leading cause of disability in 160 countries. These exoskeletons assist patients in managing their pain, as well as help regain their mobility, thereby improving their overall quality of life. Thus, the increasing prevalence of stroke and musculoskeletal disorders has led to the use of exoskeletan robotic systems for rehabilitation.

Europe Medical Exoskeleton Market Overview

The European medical exoskeleton market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global medical exoskeleton market and is expected to register a notable CAGR. Market players in the country are adopting inorganic growth strategies such as partnerships and collaborations for market expansion and growth. In August 2022, German Bionic (a global technology leader in the development of smart power suits) and Mubea (the top German automotive supplier) entered a cooperation agreement. By assisting the world's top developer of robotic exoskeletons in production, Mubea tapped into a new and quite promising future sector. Similarly, in April 2020, ReWalk Robotics Ltd. announced the national agreement with top German Statutory Health Insurers ("SHI"), Deutsche Angestellten-Krankenkasse - Gesundheit ("DAK-Gesundheit"), and Techniker Krankenkasse ("TK"). This agreement can permit any eligible beneficiary with a spinal cord injury to get a ReWalk 6.0 exoskeleton system. TK and DAK, representing 10.6 million and 5.6 million beneficiaries in Germany, respectively, are two of the largest SHIs in the country; these agreements are expected to help set the standard for exoskeleton procurement in Germany.

Europe Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

Europe Medical Exoskeleton Market Segmentation

The Europe medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the Europe medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Europe medical exoskeleton market share in 2023.

In terms of type, the Europe medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

Based on extremity, the Europe medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Europe medical exoskeleton market share in 2023.

By application, the Europe medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Europe medical exoskeleton market share in 2023.

In terms of mobility, the Europe medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

By end users, the Europe medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Europe medical exoskeleton market share in 2023.

Based on country, the Europe medical exoskeleton market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; Rex Bionics Ltd.; and Wearable Robotics SR are some of the leading companies operating in the Europe medical exoskeleton market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Medical Exoskeleton Market - Key Market Dynamics

  • 4.1 Europe Medical Exoskeleton Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Rising Number of Strategic Initiatives
    • 4.2.2 Growing Incidence of Stroke and Musculoskeletal
    • 4.2.3 Increasing Longevity of Aging Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Product and Regulatory Concerns
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Prevalence of SCI
  • 4.5 Future Trends
    • 4.5.1 Increasing Technological Advancements and Rising Investments
  • 4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - Europe Analysis

  • 5.1 Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Medical Exoskeleton Market Forecast Analysis

6. Europe Medical Exoskeleton Market Analysis - by Component

  • 6.1 Hardware
    • 6.1.1 Overview
    • 6.1.2 Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Medical Exoskeleton Market Analysis - by Type

  • 7.1 Powered Exoskeleton
    • 7.1.1 Overview
    • 7.1.2 Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Passive Exoskeleton
    • 7.2.1 Overview
    • 7.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Medical Exoskeleton Market Analysis - by Extremity

  • 8.1 Lower Body Exoskeleton
    • 8.1.1 Overview
    • 8.1.2 Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Body Exoskeleton
    • 8.2.1 Overview
    • 8.2.2 Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Full Body Exoskeleton
    • 8.3.1 Overview
    • 8.3.2 Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Medical Exoskeleton Market Analysis - by Application

  • 9.1 Spinal Cord Injury
    • 9.1.1 Overview
    • 9.1.2 Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Multiple Sclerosis
    • 9.2.1 Overview
    • 9.2.2 Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Stroke
    • 9.3.1 Overview
    • 9.3.2 Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cerebral Palsy
    • 9.4.1 Overview
    • 9.4.2 Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Parkinson's Diseases
    • 9.5.1 Overview
    • 9.5.2 Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Medical Exoskeleton Market Analysis - by Mobility

  • 10.1 Mobile Exoskeleton
    • 10.1.1 Overview
    • 10.1.2 Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Stationary Exoskeleton
    • 10.2.1 Overview
    • 10.2.2 Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Medical Exoskeleton Market Analysis - by End Users

  • 11.1 Rehabilitation Centers
    • 11.1.1 Overview
    • 11.1.2 Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Physiotherapy Centers
    • 11.2.1 Overview
    • 11.2.2 Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Long Term Care Centers
    • 11.3.1 Overview
    • 11.3.2 Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Homecare Settings
    • 11.4.1 Overview
    • 11.4.2 Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Medical Exoskeleton Market - Country Analysis

  • 12.1 Europe Medical Exoskeleton Market
    • 12.1.1 Europe Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.1.2 Germany: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.1.3 Germany: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.1.4 Germany: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.1.5 Germany: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.1.6 Germany: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.2 United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.2.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.2.1.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.2.2 United Kingdom: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.2.3 United Kingdom: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.2.4 United Kingdom: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.2.5 United Kingdom: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.2.6 United Kingdom: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.3 France: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 France: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.3.1.1 France: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.3.1.1.1 France: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.3.2 France: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.3.3 France: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.3.4 France: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.3.5 France: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.3.6 France: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.4 Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Italy: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.4.1.1 Italy: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.4.1.1.1 Italy: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.4.2 Italy: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.4.3 Italy: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.4.4 Italy: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.4.5 Italy: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.4.6 Italy: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.5 Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Spain: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.5.1.1 Spain: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.5.1.1.1 Spain: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.5.2 Spain: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.5.3 Spain: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.5.4 Spain: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.5.5 Spain: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.5.6 Spain: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.6 Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.6.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.6.1.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.6.2 Rest of Europe: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.6.3 Rest of Europe: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.6.4 Rest of Europe: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.6.5 Rest of Europe: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.6.6 Rest of Europe: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Medical Exoskeleton Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Ekso Bionics Holdings Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lifeward, Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ExoAtlet
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cyberdyne Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 BIONIK
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B-Temia Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hocoma AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Wearable Robotics SRL
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Myomo Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Rex Bionics Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms